What is Global Killed-type Poultry Vaccine Market?
The Global Killed-type Poultry Vaccine Market is a specialized segment within the broader animal health industry, focusing on vaccines that are designed to protect poultry from various infectious diseases. These vaccines are termed "killed-type" because they are made from pathogens that have been inactivated or killed, ensuring they cannot cause disease. Instead, they stimulate the bird's immune system to recognize and fight off the actual disease-causing organisms if they are encountered in the future. This market is crucial for maintaining the health and productivity of poultry, which is a significant source of protein for human consumption worldwide. The demand for these vaccines is driven by the need to prevent outbreaks of diseases that can lead to significant economic losses in the poultry industry. Additionally, as global poultry production continues to rise to meet the growing demand for meat and eggs, the importance of effective vaccination programs becomes even more pronounced. The market encompasses a range of vaccines targeting different diseases, each tailored to address specific pathogens that pose a threat to poultry health.
NDV, Marek ' s Disease, IBD, Infectious Bronchitis, Influenza, Other in the Global Killed-type Poultry Vaccine Market:
The Global Killed-type Poultry Vaccine Market addresses several critical diseases that affect poultry, including Newcastle Disease Virus (NDV), Marek's Disease, Infectious Bursal Disease (IBD), Infectious Bronchitis, and Avian Influenza, among others. NDV is a highly contagious viral disease that affects many species of domestic and wild birds, causing respiratory, nervous, and digestive symptoms. Vaccination against NDV is essential as outbreaks can lead to severe economic losses due to high mortality rates and decreased egg production. Marek's Disease is another significant concern, caused by a herpesvirus that leads to tumors and paralysis in chickens. Vaccination is the primary method of control, as it significantly reduces the incidence of the disease. Infectious Bursal Disease, also known as Gumboro disease, affects the immune system of young chickens, making them more susceptible to other infections. Vaccines are crucial in preventing this disease, ensuring the overall health and productivity of the flock. Infectious Bronchitis is a highly contagious respiratory disease that affects chickens, leading to decreased egg production and quality. Vaccination helps in controlling the spread of the virus and maintaining the health of the flock. Avian Influenza, commonly known as bird flu, is a viral infection that can affect all bird species. It poses a significant threat not only to poultry health but also to human health, making vaccination an essential tool in preventing outbreaks. Other diseases targeted by killed-type vaccines include fowl cholera, avian encephalomyelitis, and egg drop syndrome, each posing unique challenges to poultry health. The development and distribution of these vaccines are critical for ensuring the sustainability and profitability of the poultry industry, as they help in maintaining healthy flocks and preventing the spread of infectious diseases.
Chicken, Other Poultry in the Global Killed-type Poultry Vaccine Market:
The usage of Global Killed-type Poultry Vaccine Market is primarily focused on chickens, which are the most widely farmed poultry species worldwide. Chickens are susceptible to a range of infectious diseases that can significantly impact their health and productivity. Vaccination programs are an integral part of poultry management, aimed at preventing disease outbreaks and ensuring the welfare of the birds. Killed-type vaccines are particularly favored for their safety and efficacy, as they do not contain live pathogens that could potentially revert to a virulent form. These vaccines are administered to chickens at various stages of their life cycle, depending on the specific disease being targeted. For instance, vaccines against Marek's Disease are typically given to chicks shortly after hatching, while those for Infectious Bronchitis and NDV may be administered at different intervals throughout the bird's life. In addition to chickens, other poultry species such as turkeys, ducks, and quails also benefit from killed-type vaccines. While the specific diseases and vaccination protocols may vary, the underlying principle remains the same: to protect the birds from infectious diseases and ensure their health and productivity. The use of vaccines in these species is particularly important in regions where mixed-species farming is common, as the risk of disease transmission between different types of poultry can be high. Overall, the Global Killed-type Poultry Vaccine Market plays a vital role in supporting the poultry industry by providing effective tools for disease prevention and control, ultimately contributing to food security and economic stability.
Global Killed-type Poultry Vaccine Market Outlook:
In 2024, the Global Killed-type Poultry Vaccine Market was valued at approximately $3,312 million. Projections indicate that by 2031, this market is expected to grow to a revised size of around $4,429 million, reflecting a compound annual growth rate (CAGR) of 4.3% over the forecast period. This growth is indicative of the increasing demand for effective poultry vaccines as the industry seeks to address the challenges posed by infectious diseases. The importance of this market is underscored by the broader context of the global pet industry, which reached a valuation of $261 billion in 2022, marking an 11.3% increase from the previous year. This growth in the pet industry highlights the rising awareness and investment in animal health and welfare, trends that are mirrored in the poultry sector. As the demand for poultry products continues to rise globally, driven by population growth and changing dietary preferences, the need for robust vaccination programs becomes even more critical. The Global Killed-type Poultry Vaccine Market is poised to play a key role in supporting the health and productivity of poultry flocks worldwide, ensuring the sustainability and profitability of the industry.
| Report Metric | Details |
| Report Name | Killed-type Poultry Vaccine Market |
| Accounted market size in year | US$ 3312 million |
| Forecasted market size in 2031 | US$ 4429 million |
| CAGR | 4.3% |
| Base Year | year |
| Forecasted years | 2025 - 2031 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, JINYU BIOTECHNOLOGY, HARBIN PHARMACEUTICAL GROUP, MEVAC, VENKY’S |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
